Nicotine addiction is considered to be the main preventable cause of death worldwide. While growing evidence indicates that the neurohypophysial peptide oxytocin can modulate the addictive properties of several abused drugs, the regulation of the oxytonergic system following nicotine administration has so far received little attention. Here, we examined the effects of longterm nicotine or saline administration on the central oxytocinergic system using [
Introduction
Cigarette smoking is considered the main preventable cause of death worldwide [1] . While there is evidence suggesting that nicotine may exert antidepressant [2] [3] [4] [5] and anxiolytic [6] effects, chronic nicotine use has been also associated with severe depression symptoms [7] [8] [9] and anxiety, which persist following abstinence [10, 11] . This negative affective state following nicotine cessation might contribute to relapse. Although there are currently numerous therapeutic agents and cognitive behavioural interventions that are considered beneficial for the treatment of nicotine addiction, none of these therapeutic strategies has been shown to effectively prevent relapse to nicotine-seeking following abstinence [12] . Therefore, development of an optimal treatment for nicotine addiction requires further understanding of the mechanisms contributing to maintenance of cigarette use, which might be associated with the emergence of emotional impairment during withdrawal.
Emerging evidence indicates the involvement of the oxytocinergic system in drug addiction processes [13] [14] [15] . In particular, chronic administration of addictive substances including cocaine [16, 17] , methamphetamine [18] , opioids [19] and alcohol [20] have been shown to induce marked alterations in the oxytocin (OT) system in the brain, which might be involved in the modulation of the emotional consequences of chronic drug use. Indeed, recent evidence supports an association between oxytocinergic deficiency and the negative emotional consequences of drug addiction, including depression, anxiety and social deficits [19] . OT-producing neurons located in the hypothalamus also project to several brain regions involved in drug-seeking behaviour as well as emotional regulation, including the septum and amygdala, where oxytocin receptors (OTR) are expressed [21] .Few previous studies also demonstrated a role for OT in the modulation of nicotine addiction processes. In particular, acute intravenous administration of nicotine has been shown to decrease OT content in the pituitary of rats [22] , and systemic administration of OT abolished physical somatic symptoms of nicotine withdrawal in rats [23] .
Overall, although these studies clearly support the involvement of OT in nicotine addiction, the effects of chronic nicotine administration on the central oxytocinergic system remains largely unknown.
Based on the evidence implicating the OT neuropeptidergic system in addictive-related behaviours, we hypothesized that chronic nicotine administration might also induce alterations in the central oxytocinergic system. This is the first study to investigate the effects of chronic nicotine treatment on oxytocin receptor binding with the use of autoradiographic binding.
Materials and Methods

Animals and chronic nicotine administration paradigm
Male C57BL/6J mice (seven-week old, Charles River Laboratories, Kingston, UK), were individually housed in a temperature-controlled environment with a 12:12-hour light/dark cycle (lights on at 06:00). Food and water were available ad libitum. Mice were given seven days to acclimatize to their new environment and were handled daily by the experimenter. Mice were treated with a nicotine administration paradigm as described previously [24] . Briefly, saline or nicotine hydrogen salt (7.8 mg/kg/day; Sigma-Aldrich, UK) were administered via osmotic minipumps (ALZET®2002 model, Charles River, UK). For minipump implantation, mice were anaesthetised using an isoflurane/oxygen vapour mixture (3.5%-4.5%; Isoflo, Abbott Laboratories Ltd, UK). A single incision along the midline of the back of each animal was made and osmotic mini-pumps were placed in parallel position to the spine. The flow operator was pointing away from the incision site. Nicotine was delivered for a period of 14 days at the daily dose of 7.8 mg/kg (free-base weight), at a rate of 0.5 μl per hour. This dose has been shown to induce blood nicotine levels comparable to the values measured in human smokers [24] .
All animal care and experimental procedures complied with protocols approved by the
University of Surrey Animal Welfare and Ethical Review Body and by the UK Home
Officeunder Animals (Scientific Procedures) Act 1986. Mice were randomly assigned to two different drug-administration groups; control saline-treated group and chronic nicotine-treated group.
OTR autoradiography
OTR binding was carried out on sections from 14-day saline-and nicotine-treated mice as previously described [18] 
Statistical Analysis
All values were expressed as mean ± SEM. For the analysis of regional OTR binding, two-way ANOVA was performed for factors 'treatment (saline/nicotine)' and 'brain region' in different bregmas. Bonferroni post-hoc test was used when ANOVA reached significance (i.e., p<0.05).
All statistical analyses were performed using Statistica 8.0 (Statsoft Inc., France). 
Results
High
Discussion
The present study demonstrated, for the first time, a region-specific alteration of the OTR binding in the brain of mice treated with a chronic nicotine administration paradigm. This upregulation of the OTR was specifically localized in the amygdala, a region involved in stress and emotional regulation [25, 26] . Therefore, this oxytocinergic system alteration may be involved in the modulation of long-term behavioural adaptations induced by chronic nicotine exposure.
Expression and distribution of the OTR observed in the current study is in line with previous published data in mice [e.g. 18, 27] . Although alterations of the endogenous oxytocin system have been previously demonstrated following acute or chronic alcohol [28] , cocaine [16, 17, 29] , methamphetamine [18] , 3,4-methylenedioxymethamphetamine (MDMA) [30] and morphine [19, 31, 32] administration in the brain of rodents, this is the first study to report central oxytocinergic neuroadaptations following chronic nicotine administration. The up-regulation of OTR binding in the amygdala observed in the present study, is in line with studies investigating the effects of chronic opioid, cocaine and methamphetamine administration on the central oxytocinergic system [17, 18, 33] , indicating a possible common mechanism of action of several drugs of abuse through the modulation of the amygdalar OTR.
The role of this nicotine-induced increase in OTR binding is yet to be determined. However, given the involvement of the amygdala in a number of facets of emotional regulation [25] and social cognition [34] , we can postulate that the alterations observed in this study might reflect neuroadaptations of the OT system in response to emotional and cognitive impairments induced by chronic nicotine. Indeed, chronic nicotine administration has been shown to induce emotional deficits, including depression and anxiety [10] . This hypothesis is further supported by findings demonstrating that the anxiolytic, antidepressant and stress-relieving properties of OT to be at least partly modulated by the amygdala [35] .
Nicotine administration has been also shown to exert cognition-enhancing effects [36] . Since oxytocin is also considered as a key mediator of social cognition in humans [37] and this effect has been postulated to specifically involve the OT system in the Amy [38] , the OTR upregulation observed here might also be associated with a possible nicotine regulation of cognition through an OTR-dependent mechanism. However, this hypothesis needs to be further investigated.
Importantly, alterations of OTR in the amygdala have been previously associated with a hypooxytocinergic tone in the brain. In particular, chronic morphine administration and withdrawal induced a marked decrease in the hypothalamic OT levels, concomitant with a rebound increase of the OTR in the Amy [19] . Considering these findings and since an increase in OT peptide levels or administration of an OTR agonist induces rapid OTR desensitization, clathrindependent internalisation and subsequent downregulation of the receptors [39] , we can speculate that the up-regulation of OTR in the amygdala is a rebound consequence of a possible reduction of OT levels in the brain following chronic nicotine administration. Indeed, there is evidence for a reduced oxytocinergic tone following nicotine administration, as acute nicotine was shown to diminish OT levels in the pituitary of rats [22] .
In conclusion, this is the first study to demonstrate direct brain region-specific alterations in the amygdalar OTR following nicotine administration in mice. This study suggests the alterations of OTR as one possible mechanism underlying behavioural and neurochemical alterations observed in nicotine addiction and highlights the potential of OT-based pharmacotherapies for the treatment of nicotine addiction.
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